PathoQuest Raises $4.96M From Idinvest, Aurinvest, Kurma
PathoQuest said it raised about $4.96 million from new investors Idinvest and Aurinvest, and existing investor Kurma Life Science Partners. PathoQuest is a molecular diagnostics company.
12 July 2013•4 mins read
